New insights into the genetic basis of infertility

License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php The Application of Clinical Genetics 2014:7 235–243 The Application of Clinical Genetics Dovepress

[1]  K. Kwack,et al.  Epistasis between polymorphisms in PCSK1 and DBH is associated with premature ovarian failure , 2014, Menopause.

[2]  K. Kwack,et al.  Epistasis between polymorphisms in TSHB and ADAMTS16 is associated with premature ovarian failure , 2014, Menopause.

[3]  Y. Bassiouny,et al.  Association of the luteinizing hormone/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  A. Grüters,et al.  Analysis of the gene coding for steroidogenic factor 1 (SF1, NR5A1) in a cohort of 50 Egyptian patients with 46,XY disorders of sex development. , 2014, European journal of endocrinology.

[5]  V. Sutton,et al.  State of the art review in gonadal dysgenesis: challenges in diagnosis and management , 2014, International Journal of Pediatric Endocrinology.

[6]  F. Pouresmaeili,et al.  Premature Ovarian Failure: A Critical Condition in The Reproductive Potential with Various Genetic Causes , 2014, International journal of fertility & sterility.

[7]  Zi-jiang Chen,et al.  Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome. , 2014, Endocrinology.

[8]  Huan Wang,et al.  Quantitative Methylation Level of the EPHX1 Promoter in Peripheral Blood DNA Is Associated with Polycystic Ovary Syndrome , 2014, PloS one.

[9]  A. Tolun,et al.  Truncating mutations in TAF4B and ZMYND15 causing recessive azoospermia , 2014, Journal of Medical Genetics.

[10]  X. Bi,et al.  Association between FSHR polymorphisms and polycystic ovary syndrome among Chinese women in north China , 2014, Journal of Assisted Reproduction and Genetics.

[11]  R. Alvero,et al.  Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome , 2014, Journal of Assisted Reproduction and Genetics.

[12]  B. Persson,et al.  Novel candidate genes for 46,XY gonadal dysgenesis identified by a customized 1 M array-CGH platform. , 2013, European journal of medical genetics.

[13]  G. Guerra‐Júnior,et al.  Screening of Y chromosome microdeletions in 46,XY partial gonadal dysgenesis and in patients with a 45,X/46,XY karyotype or its variants , 2013, BMC Medical Genetics.

[14]  D. Das,et al.  Mutation analysis of mitogen activated protein kinase 1 gene in Indian cases of 46,XY disorder of sex development , 2013, Indian journal of human genetics.

[15]  J. Słowikowska-Hilczer,et al.  A novel mutation (c. 341A>G) in the SRY gene in a 46,XY female patient with gonadal dysgenesis. , 2013, Gene.

[16]  K. Lee,et al.  Various endocrine disorders in children with t(13;14)(q10;q10) Robertsonian translocation , 2013, Annals of pediatric endocrinology & metabolism.

[17]  M. Bagheri,et al.  Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk , 2013, International journal of fertility & sterility.

[18]  M. Thangavelu,et al.  Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review , 2013, Journal of Assisted Reproduction and Genetics.

[19]  C. Niederberger.  Re: Epigenetic disruption of the PIWI pathway in human spermatogenic disorders. , 2013, The Journal of urology.

[20]  W. Di,et al.  Genome-Wide Methylated DNA Immunoprecipitation Analysis of Patients with Polycystic Ovary Syndrome , 2013, PloS one.

[21]  Md. Munir Hossain,et al.  Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model , 2013, Journal of Ovarian Research.

[22]  W. Ting,et al.  The Relationship Between Insulin Resistance and CpG Island Methylation of LMNA Gene in Polycystic Ovary Syndrome , 2013, Cell Biochemistry and Biophysics.

[23]  T. Walsh,et al.  Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in Perrault syndrome. , 2013, American journal of human genetics.

[24]  G. Palermo,et al.  Downregulation of store-operated Ca2+ entry during mammalian meiosis is required for the egg-to-embryo transition , 2013, Journal of Cell Science.

[25]  Qiupeng Zheng,et al.  Association study between FSHR Ala307Thr and Ser680Asn variants and polycystic ovary syndrome (PCOS) in Northern Chinese Han women , 2013, Journal of Assisted Reproduction and Genetics.

[26]  D. Conrad,et al.  Human Spermatogenic Failure Purges Deleterious Mutation Load from the Autosomes and Both Sex Chromosomes, including the Gene DMRT1 , 2013, PLoS genetics.

[27]  Seth R. Flaxman,et al.  National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys , 2012, PLoS medicine.

[28]  P. Noveski,et al.  Genetic Causes of Male Infertility , 2012, Balkan journal of medical genetics : BJMG.

[29]  J. Chen,et al.  Regulation of male fertility by CFTR and implications in male infertility. , 2012, Human reproduction update.

[30]  D. Wells,et al.  Embryos of Robertsonian Translocation Carriers Exhibit a Mitotic Interchromosomal Effect That Enhances Genetic Instability during Early Development , 2012, PLoS genetics.

[31]  Ling Li,et al.  Co action of CFTR and AQP1 increases permeability of peritoneal epithelial cells on estrogen-induced ovarian hyper stimulation syndrome , 2012, BMC Cell Biology.

[32]  C. Barbieri,et al.  Deletion or underexpression of the Y-chromosome genes CDY2 and HSFY is associated with maturation arrest in American men with nonobstructive azoospermia. , 2012, Asian journal of andrology.

[33]  P. Wieacker,et al.  Partial deletion of DMRT1 causes 46,XY ovotesticular disorder of sexual development. , 2012, European journal of endocrinology.

[34]  D. Carrell,et al.  The sperm epigenome and potential implications for the developing embryo. , 2012, Reproduction.

[35]  David Handelsman,et al.  Rodent Models for Human Polycystic Ovary Syndrome1 , 2012, Biology of reproduction.

[36]  M. Polak,et al.  Screening of MAMLD1 Mutations in 70 Children with 46,XY DSD: Identification and Functional Analysis of Two New Mutations , 2012, PloS one.

[37]  Ayal B. Gussow,et al.  XX ovarian dysgenesis is caused by a PSMC3IP/HOP2 mutation that abolishes coactivation of estrogen-driven transcription. , 2011, American journal of human genetics.

[38]  J. Charron,et al.  The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility. , 2011, Molecular endocrinology.

[39]  T. Walsh,et al.  Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome , 2011, Proceedings of the National Academy of Sciences.

[40]  T. Walsh,et al.  Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome. , 2010, American journal of human genetics.

[41]  K. Baek,et al.  Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome. , 2010, International journal of molecular medicine.

[42]  D. Lamb,et al.  The use of fluorescent in situ hybridization in male infertility , 2010, Therapeutic advances in urology.

[43]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[44]  A. Bideci,et al.  Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome , 2009, Journal of Assisted Reproduction and Genetics.

[45]  Gopenath Ts,et al.  Genetics of human male infertility. , 2009, Singapore medical journal.

[46]  K. McElreavey,et al.  Mutations in NR5A1 associated with ovarian insufficiency. , 2009, The New England journal of medicine.

[47]  Martin M Matzuk,et al.  The biology of infertility: research advances and clinical challenges , 2008, Nature Medicine.

[48]  I. Cooke,et al.  Infertility and the provision of infertility medical services in developing countries , 2008, Human reproduction update.

[49]  B. Destenaves,et al.  disorders: Part I: polycystic ovary syndrome , 2008 .

[50]  A. Lenzi,et al.  Molecular and clinical characterization of Y chromosome microdeletions in infertile men: a 10-year experience in Italy. , 2007, The Journal of clinical endocrinology and metabolism.

[51]  S. Bione,et al.  Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. , 2006, Human reproduction.

[52]  H. Tournaye,et al.  The choice and outcome of the fertility treatment of 38 couples in whom the male partner has a Yq microdeletion. , 2006, Human reproduction.

[53]  O. Boespflug-Tanguy,et al.  The large spectrum of eIF2B-related diseases. , 2006, Biochemical Society transactions.

[54]  B. Delobel,et al.  Interchromosomal effect in sperm of males with translocations: report of 6 cases and review of the literature. , 2005, International journal of andrology.

[55]  Bruno Dallapiccola,et al.  Screening of mutations in the CFTR gene in 1195 couples entering assisted reproduction technique programs , 2005, European Journal of Human Genetics.

[56]  A. Cheung,et al.  Increased cystic fibrosis transmembrane conductance regulator (CFTR) expression in the human hydrosalpinx. , 2005, Human reproduction.

[57]  L. Jakubowski.  [Genetic aspects of polycystic ovary syndrome]. , 2005, Endokrynologia Polska.

[58]  M. Sousa,et al.  Unique t(Y;1)(q12;q12) reciprocal translocation with loss of the heterochromatic region of chromosome 1 in a male with azoospermia due to meiotic arrest: a case report. , 2005, Human reproduction.

[59]  A. Themmen,et al.  Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis. , 2005, European journal of endocrinology.

[60]  O. Rennert,et al.  Leydig cell hypoplasia due to inactivation of luteinizing hormone receptor by a novel homozygous nonsense truncation mutation in the seventh transmembrane domain , 2005, Molecular and Cellular Endocrinology.

[61]  K. Brøndum‐Nielsen.  Chromosome Abnormalities and Genetic Counselling , 2004, European Journal of Human Genetics.

[62]  H. Chan,et al.  Involvement of CFTR in uterine bicarbonate secretion and the fertilizing capacity of sperm , 2003, Nature Cell Biology.

[63]  H. Tempest,et al.  The genetic basis of infertility. , 2003, Reproduction.

[64]  S. Oehninger,et al.  Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction. , 2002, Human reproduction.

[65]  M. Mühlmann.  Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions. , 2002, Genetics and molecular research : GMR.

[66]  R. Wilson,et al.  The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men , 2001, Nature Genetics.

[67]  S. Ng,et al.  Absence of Mutations in the Coding Regions of Follicle-Stimulating Hormone Receptor Gene in Singapore Chinese Women with Premature Ovarian Failure and Polycystic Ovary Syndrome , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[68]  M. Hurles,et al.  Divergent outcomes of intrachromosomal recombination on the human Y chromosome: male infertility and recurrent polymorphism , 2000, Journal of medical genetics.

[69]  S. Rozen,et al.  Deletion of azoospermia factor a (AZFa) region of human Y chromosome caused by recombination between HERV15 proviruses. , 2000, Human molecular genetics.

[70]  L. Quintana-Murci,et al.  Prognostic value of Y deletion analysis: what is the clinical prognostic value of Y chromosome microdeletion analysis? , 2000, Human reproduction.

[71]  A. Shelling.  X chromosome defects and premature ovarian failure. , 2000, Australian and New Zealand journal of medicine.

[72]  O. Rennert,et al.  Luteinizing Hormone Receptor Mutations in Disorders of Sexual Development and Cancer , 2000, Frontiers in bioscience : a journal and virtual library.

[73]  A. Handyside,et al.  Chromosome translocations: segregation modes and strategies for preimplantation genetic diagnosis , 1998, Prenatal diagnosis.

[74]  D. Waterworth,et al.  Genetics of polycystic ovary syndrome , 1998, Molecular and Cellular Endocrinology.

[75]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[76]  S. Coker,et al.  Neurologic anomalies of Perrault syndrome. , 1996, American journal of medical genetics.

[77]  J. Riordan,et al.  Phenotypic Abnormalities in Long-Term Surviving Cystic Fibrosis Mice , 1996, Pediatric Research.

[78]  A. Edelmann,et al.  Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. , 1996, Human molecular genetics.

[79]  I. Verma,et al.  Mixed gonadal dysgenesis and dysgenetic male pseudohermaphroditism—A critical analysis , 1992, Indian journal of pediatrics.

[80]  C. Denniston,et al.  The nonrandom participation of human acrocentric chromosomes in Robertsonian translocations , 1989, Annals of human genetics.

[81]  O. Zuffardi,et al.  Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human y chromosome long arm , 1976, Human Genetics.

[82]  M. Urbanek,et al.  Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. , 2013, The Journal of clinical endocrinology and metabolism.

[83]  H. Tournaye,et al.  Genetic causes of spermatogenic failure. , 2012, Asian journal of andrology.

[84]  B. Zhang,et al.  Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 , 2011, Nature Genetics.

[85]  M. Gaware.V.,et al.  Female infertility and its treatment by alternative medicine: A review , 2009 .

[86]  A. Röpke,et al.  BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure. , 2008, American Journal of Obstetrics and Gynecology.

[87]  M. QUINTONPaul.  Too much salt , too little soda : cystic fibrosis , 2007 .

[88]  K. Shiraishi,et al.  Lutropin/choriogonadotropin (LH/CG) stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the ERK1/2 cascade , 2007 .

[89]  S. Kropf,et al.  Increased frequency of cystic fibrosis transmembrane conductance regulator gene mutations in infertile males. , 2006, Fertility and sterility.

[90]  S. Munné,et al.  Negligible interchromosomal effect in embryos of Robertsonian translocation carriers. , 2005, Reproductive biomedicine online.